Cargando…
Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity
BACKGROUND: Emerging biomarkers from medical imaging or molecular characterization of tumour biopsies open up for combining the two and exploiting their synergy in treatment planning of cancer patients. We generated a paired data set of imaging- and gene-based hypoxia biomarkers in cervical cancer,...
Autores principales: | Fjeldbo, Christina S., Hompland, Tord, Hillestad, Tiril, Aarnes, Eva-Katrine, Günther, Clara-Cecilie, Kristensen, Gunnar B., Malinen, Eirik, Lyng, Heidi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317686/ https://www.ncbi.nlm.nih.gov/pubmed/32580139 http://dx.doi.org/10.1016/j.ebiom.2020.102841 |
Ejemplares similares
-
miR‐200a/b/‐429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer
por: Nilsen, Anja, et al.
Publicado: (2022) -
Identification and Validation of Reference Genes for RT-qPCR Studies of Hypoxia in Squamous Cervical Cancer Patients
por: Fjeldbo, Christina S., et al.
Publicado: (2016) -
Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter
por: Hompland, Tord, et al.
Publicado: (2021) -
A prognostic hypoxia gene signature with low heterogeneity within the dominant tumour lesion in prostate cancer patients
por: Salberg, Unn Beate, et al.
Publicado: (2022) -
Reference MicroRNAs for RT-qPCR Assays in Cervical Cancer Patients and Their Application to Studies of HPV16 and Hypoxia Biomarkers()()
por: Nilsen, Anja, et al.
Publicado: (2019)